Cargando…
Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin
BACKGROUND: Platinum-based chemotherapy is a standard strategy for non-small cell lung cancer (NSCLC), while chemoresistance remains a major therapeutic challenge in current clinical practice. Our present study was aimed to determine whether inhibition of the NF-κB/miR-21/PTEN pathway could increase...
Autores principales: | Yang, Zhenhua, Fang, Surong, Di, Yicheng, Ying, Weiwei, Tan, Yan, Gu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370674/ https://www.ncbi.nlm.nih.gov/pubmed/25799148 http://dx.doi.org/10.1371/journal.pone.0121547 |
Ejemplares similares
-
LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
por: Du, Ying, et al.
Publicado: (2022) -
TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis
por: Xiao, Huijuan, et al.
Publicado: (2018) -
MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN
por: Xue, Xinying, et al.
Publicado: (2016) -
miR-21 regulates osteogenic and adipogenic differentiation of BMSCs by targeting PTEN
por: Zhou, Yongtao, et al.
Publicado: (2021) -
miR-383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24-mediated NF-κB signaling pathway
por: He, Bo, et al.
Publicado: (2021)